Legal & General Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.3M Sell
254,331
-9,493
-4% -$570K ﹤0.01% 991
2025
Q4
$15.5M Sell
263,824
-59,274
-18% -$3.6M ﹤0.01% 954
2025
Q3
$18M Sell
323,098
-233,735
-42% -$12.5M ﹤0.01% 914
2025
Q2
$28.6M Sell
556,833
-186,173
-25% -$9.35M 0.01% 738
2025
Q1
$43.6M Buy
743,006
+25,784
+4% +$1.75M 0.01% 642
2024
Q4
$51.7M Sell
717,222
-1,328
-0.2% -$97.5K 0.01% 617
2024
Q3
$57.4M Buy
718,550
+25,960
+4% +$1.95M 0.02% 609
2024
Q2
$49.6M Sell
692,590
-73,584
-10% -$5.42M 0.01% 624
2024
Q1
$53.9M Sell
766,174
-28,476
-4% -$2.04M 0.02% 618
2023
Q4
$61.3M Sell
794,650
-87,129
-10% -$5.74M 0.02% 589
2023
Q3
$60M Sell
881,779
-72,074
-8% -$5.69M 0.02% 582
2023
Q2
$77.9M Buy
953,853
+38,653
+4% +$3.11M 0.03% 540
2023
Q1
$67.9M Sell
915,200
-77,552
-8% -$5.98M 0.02% 562
2022
Q4
$82.3M Buy
992,752
+28,140
+3% +$2.23M 0.03% 508
2022
Q3
$68.5M Sell
964,612
-40,192
-4% -$3.47M 0.03% 553
2022
Q2
$87.1M Sell
1,004,804
-89,776
-8% -$8.41M 0.03% 529
2022
Q1
$118M Buy
1,094,580
+27,232
+3% +$2.81M 0.04% 485
2021
Q4
$138M Sell
1,067,348
-25,216
-2% -$3.09M 0.04% 450
2021
Q3
$132M Buy
1,092,564
+333,196
+44% +$40.6M 0.04% 451
2021
Q2
$85.5M Buy
759,368
+403,220
+113% +$42.4M 0.03% 574
2021
Q1
$34M Buy
356,148
+18,048
+5% +$1.65M 0.01% 741
2020
Q4
$26.8M Sell
338,100
-255,488
-43% -$18.5M 0.01% 766
2020
Q3
$36.8M Buy
593,588
+242,088
+69% +$15.7M 0.02% 671
2020
Q2
$23.2M Sell
351,500
-4,872
-1% -$292K 0.01% 754
2020
Q1
$16.9M Buy
356,372
+2,644
+0.7% +$132K 0.01% 779
2019
Q4
$19.4M Buy
353,728
+21,956
+7% +$1.15M 0.01% 818
2019
Q3
$16.2M Buy
331,772
+5,124
+2% +$257K 0.01% 834
2019
Q2
$17M Buy
326,648
+135,796
+71% +$6.84M 0.01% 821
2019
Q1
$9.47M Buy
190,852
+8,656
+5% +$390K 0.01% 908
2018
Q4
$6.59M Buy
182,196
+6,548
+4% +$274K 0.01% 947
2018
Q3
$8.96M Buy
175,648
+2,164
+1% +$95.9K 0.01% 903
2018
Q2
$6.42M Sell
173,484
-3,116
-2% -$119K 0.01% 1006
2018
Q1
$6.67M Buy
176,600
+25,396
+17% +$897K 0.01% 964
2017
Q4
$4.9M Buy
151,204
+15,392
+11% +$489K ﹤0.01% 1104
2017
Q3
$4.11M Buy
135,812
+13,828
+11% +$410K ﹤0.01% 1151
2017
Q2
$3.58M Buy
121,984
+24,832
+26% +$679K ﹤0.01% 1176
2017
Q1
$2.47M Buy
97,152
+53,592
+123% +$1.38M ﹤0.01% 1345
2016
Q4
$1.12M Buy
43,560
+21,644
+99% +$569K ﹤0.01% 1694
2016
Q3
$600K Buy
21,916
+2,240
+11% +$61.5K ﹤0.01% 1613
2016
Q2
$555K Buy
19,676
+828
+4% +$21.3K ﹤0.01% 1302
2016
Q1
$446K Buy
18,848
+2,772
+17% +$61K ﹤0.01% 1353
2015
Q4
$362K Buy
16,076
+1,368
+9% +$31.2K ﹤0.01% 1454
2015
Q3
$340K Buy
14,708
+996
+7% +$25K ﹤0.01% 1426
2015
Q2
$338K Buy
13,712
+5,700
+71% +$142K ﹤0.01% 1486
2015
Q1
$201K Buy
8,012
+4,428
+124% +$105K ﹤0.01% 1677
2014
Q4
$83K Hold
3,584
﹤0.01% 2106
2014
Q3
$84K Hold
3,584
﹤0.01% 2015
2014
Q2
$83K Hold
3,584
﹤0.01% 1298
2014
Q1
$76K Hold
3,584
﹤0.01% 1267
2013
Q4
$85K Buy
+3,584
New +$77.7K ﹤0.01% 1281

Other funds holding TECH

Legal & General Group's TECH Position: Q1 2026 in Review

Legal & General Group reduced its Bio-Techne (TECH) stake by 3.6% in Q1 2026, selling an estimated $570K and leaving 254,331 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Legal & General Group first reported a position in TECH in Q4 2013 and has held it in 50 quarters since. The position peaked at $138M in Q4 2021. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Legal & General Group held 254,331 shares of Bio-Techne worth $13.3M as of Q1 2026.
  • Legal & General Group sold 9,493 Bio-Techne shares in Q1 2026, an estimated $570K.
  • Bio-Techne made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #991 holding.
  • Legal & General Group first reported a position in Bio-Techne in Q4 2013 and has held it in 50 quarters since.
  • Legal & General Group's Bio-Techne position peaked at $138M in Q4 2021.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.